BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: West NR, McCuaig S, Franchini F, Powrie F. Emerging cytokine networks in colorectal cancer. Nat Rev Immunol. 2015;15:615-629. [PMID: 26358393 DOI: 10.1038/nri3896] [Cited by in Crossref: 184] [Cited by in F6Publishing: 176] [Article Influence: 30.7] [Reference Citation Analysis]
Number Citing Articles
1 Caramujo-Balseiro S, Faro C, Carvalho L. Metabolic pathways in sporadic colorectal carcinogenesis: A new proposal. Med Hypotheses 2021;148:110512. [PMID: 33548761 DOI: 10.1016/j.mehy.2021.110512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Das S, Doñas C, Akeus P, Quiding-Järbrink M, Mora JR, Villablanca EJ. β7 integrins contribute to intestinal tumor growth in mice. PLoS One 2018;13:e0204181. [PMID: 30235302 DOI: 10.1371/journal.pone.0204181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Zhang Y, Yu X, Yu E, Wang N, Cai Q, Shuai Q, Yan F, Jiang L, Wang H, Liu J, Chen Y, Li Z, Jiang Q. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. BMC Microbiol. 2018;18:92. [PMID: 30157754 DOI: 10.1186/s12866-018-1232-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
4 Cao Y, Jiao N, Sun T, Ma Y, Zhang X, Chen H, Hong J, Zhang Y. CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer. Front Cell Dev Biol 2021;9:646252. [PMID: 33777950 DOI: 10.3389/fcell.2021.646252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Calu V, Ionescu A, Stanca L, Geicu OI, Iordache F, Pisoschi AM, Serban AI, Bilteanu L. Key biomarkers within the colorectal cancer related inflammatory microenvironment. Sci Rep 2021;11:7940. [PMID: 33846436 DOI: 10.1038/s41598-021-86941-5] [Reference Citation Analysis]
6 Papila KB, Sozer V, Cigdem KP, Durmus S, Kurtulus D, Papila C, Gelisgen R, Uzun H. Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer. J Med Biochem 2021;40:150-9. [PMID: 33776564 DOI: 10.5937/jomb0-27128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sajib S, Zahra FT, Lionakis MS, German NA, Mikelis CM. Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions. Angiogenesis 2018;21:1-14. [PMID: 29110215 DOI: 10.1007/s10456-017-9583-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
8 Li M, Yue GG, Song LH, Huang MB, Lee JK, Tsui SK, Fung KP, Tan NH, Lau CB. Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway. Biochem Pharmacol 2018;150:191-201. [PMID: 29454618 DOI: 10.1016/j.bcp.2018.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
9 Budithi A, Su S, Kirshtein A, Shahriyari L. Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer. Cancers (Basel) 2021;13:2632. [PMID: 34071939 DOI: 10.3390/cancers13112632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Binder H, Hopp L, Schweiger MR, Hoffmann S, Jühling F, Kerick M, Timmermann B, Siebert S, Grimm C, Nersisyan L, Arakelyan A, Herberg M, Buske P, Loeffler-wirth H, Rosolowski M, Engel C, Przybilla J, Peifer M, Friedrichs N, Moeslein G, Odenthal M, Hussong M, Peters S, Holzapfel S, Nattermann J, Hueneburg R, Schmiegel W, Royer-pokora B, Aretz S, Kloth M, Kloor M, Buettner R, Galle J, Loeffler M. Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome: Genomic and transcriptomic heterogeneity of Lynch syndrome in colon. J Pathol 2017;243:242-54. [DOI: 10.1002/path.4948] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
11 Hu M, Xie F, Zhang S, Qi B, Li Y. Effect of nanoemulsion particle size on the bioavailability and bioactivity of perilla oil in rats. J Food Sci 2021;86:206-14. [PMID: 33295031 DOI: 10.1111/1750-3841.15537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Huang JR, Wang ST, Wei MN, Liu K, Fu JW, Xing ZH, Shi Z. Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer. Front Pharmacol 2020;11:586885. [PMID: 33343354 DOI: 10.3389/fphar.2020.586885] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shohan M, Dehghani R, Khodadadi A, Dehnavi S, Ahmadi R, Joudaki N, Houshmandfar S, Shamshiri M, Shojapourian S, Bagheri N. Interleukin-22 and intestinal homeostasis: Protective or destructive? IUBMB Life 2020;72:1585-602. [PMID: 32365282 DOI: 10.1002/iub.2295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Zhao X, Qi X, Lian W, Tong X, Wang H, Su L, Wei P, Zhuang Z, Gong J, Bai L. Trichomicin Suppresses Colorectal Cancer via Comprehensive Regulation of IL-6 and TNFα in Tumor Cells, TAMs, and CAFs. Front Pharmacol 2020;11:386. [PMID: 32317968 DOI: 10.3389/fphar.2020.00386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hoffmann W. Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives. Int J Mol Sci 2021;22:4909. [PMID: 34066339 DOI: 10.3390/ijms22094909] [Reference Citation Analysis]
16 Song J, Chen Z, Geng T, Wang M, Yi S, Liu K, Zhou W, Gao J, Song W, Tang H. Deleting MyD88 signaling in myeloid cells promotes development of adenocarcinomas of the colon. Cancer Lett 2018;433:65-75. [PMID: 29960049 DOI: 10.1016/j.canlet.2018.06.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Saurer L, Zysset D, Rihs S, Mager L, Gusberti M, Simillion C, Lugli A, Zlobec I, Krebs P, Mueller C. TREM-1 promotes intestinal tumorigenesis. Sci Rep. 2017;7:14870. [PMID: 29093489 DOI: 10.1038/s41598-017-14516-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
18 West NR. Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines. Front Immunol 2019;10:1093. [PMID: 31156640 DOI: 10.3389/fimmu.2019.01093] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
19 Garo LP, Ajay AK, Fujiwara M, Gabriely G, Raheja R, Kuhn C, Kenyon B, Skillin N, Kadowaki-Saga R, Saxena S, Murugaiyan G. MicroRNA-146a limits tumorigenic inflammation in colorectal cancer. Nat Commun 2021;12:2419. [PMID: 33893298 DOI: 10.1038/s41467-021-22641-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wlochowitz D, Haubrock M, Arackal J, Bleckmann A, Wolff A, Beißbarth T, Wingender E, Gültas M. Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines. Front Genet 2016;7:42. [PMID: 27092172 DOI: 10.3389/fgene.2016.00042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
21 Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787-820. [PMID: 34074695 DOI: 10.1101/gad.348226.120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Galaine J, Turco C, Vauchy C, Royer B, Mercier-Letondal P, Queiroz L, Loyon R, Mouget V, Boidot R, Laheurte C, Lakkis Z, Jary M, Adotévi O, Borg C, Godet Y. CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin. Int J Cancer 2019;145:3112-25. [PMID: 31396953 DOI: 10.1002/ijc.32620] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
23 Metidji A, Omenetti S, Crotta S, Li Y, Nye E, Ross E, Li V, Maradana MR, Schiering C, Stockinger B. The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity. Immunity 2018; 49: 353-362. e5. [PMID: 30119997 DOI: 10.1016/j.immuni.2018.07.010] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 36.7] [Reference Citation Analysis]
24 Yang J, Jones MS, Ramos RI, Chan AA, Lee AF, Foshag LJ, Sieling PA, Faries MB, Lee DJ. Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin. Front Oncol 2017;7:61. [PMID: 28424760 DOI: 10.3389/fonc.2017.00061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
25 Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E, Peredo IH, Dodoo E, Maeurer M. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine 2018;33:49-56. [PMID: 30049387 DOI: 10.1016/j.ebiom.2018.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Zhao Q, Guo J, Cheng X, Liao Y, Bi Y, Gong Y, Zhang X, Guo Y, Wang X, Yu W, Jin S, Tan Y, Yu X. RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis. Front Oncol 2021;11:664927. [PMID: 33996591 DOI: 10.3389/fonc.2021.664927] [Reference Citation Analysis]
27 Wu X, Xue L, Tata A, Song M, Neto CC, Xiao H. Bioactive Components of Polyphenol-Rich and Non-Polyphenol-Rich Cranberry Fruit Extracts and Their Chemopreventive Effects on Colitis-Associated Colon Cancer. J Agric Food Chem 2020;68:6845-53. [PMID: 32390426 DOI: 10.1021/acs.jafc.0c02604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
28 Ponce LF, García-Martínez K, León K. Quantitative assessment of extracellular IL-1 regulation. J Theor Biol 2020;487:110113. [PMID: 31830463 DOI: 10.1016/j.jtbi.2019.110113] [Reference Citation Analysis]
29 Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529:307-315. [PMID: 26791721 DOI: 10.1038/nature17039] [Cited by in Crossref: 349] [Cited by in F6Publishing: 319] [Article Influence: 69.8] [Reference Citation Analysis]
30 Vendramini-costa DB, Alcaide A, Pelizzaro-rocha KJ, Talero E, Ávila-román J, Garcia-mauriño S, Pilli RA, de Carvalho JE, Motilva V. Goniothalamin prevents the development of chemically induced and spontaneous colitis in rodents and induces apoptosis in the HT-29 human colon tumor cell line. Toxicology and Applied Pharmacology 2016;300:1-12. [DOI: 10.1016/j.taap.2016.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
31 Cervena K, Siskova A, Buchler T, Vodicka P, Vymetalkova V. Methylation-Based Therapies for Colorectal Cancer. Cells 2020;9:E1540. [PMID: 32599894 DOI: 10.3390/cells9061540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Yang ZH, Dang YQ, Ji G. Role of epigenetics in transformation of inflammation into colorectal cancer. World J Gastroenterol 2019; 25(23): 2863-2877 [PMID: 31249445 DOI: 10.3748/wjg.v25.i23.2863] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
33 Ying K, Bai B, Gao X, Xu Y, Wang H, Xie B. Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer. Front Bioeng Biotechnol 2021;9:670124. [PMID: 34307319 DOI: 10.3389/fbioe.2021.670124] [Reference Citation Analysis]
34 Qiu Z, Hu J, Li Z, Yang X, Hu J, You Q, Bai S, Mao Y, Hua D, Yin J. Graphene oxide-based nanocomposite enabled highly efficient targeted synergistic therapy for colorectal cancer. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020;593:124585. [DOI: 10.1016/j.colsurfa.2020.124585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
35 Kim DS, Kwon NS, Yun HY. Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non-small cell lung cancer. Oncol Lett 2019;18:3388-98. [PMID: 31452819 DOI: 10.3892/ol.2019.10648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hu B, Qin C, Li L, Wei L, Mo X, Fan H, Lei Y, Wei F, Zou D. Midkine promotes glioblastoma progression via PI3K-Akt signaling. Cancer Cell Int 2021;21:509. [PMID: 34556138 DOI: 10.1186/s12935-021-02212-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, Li J, Wang G, Lan Z, Li J, Tang M, Jiang S, Ma X, Chen P, Katkhuda R, Korphaisarn K, Chakravarti D, Chang A, Spring DJ, Chang Q, Zhang J, Maru DM, Maeda DY, Zebala JA, Kopetz S, Wang YA, DePinho RA. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell 2019; 35: 559-572. e7. [PMID: 30905761 DOI: 10.1016/j.ccell.2019.02.008] [Cited by in Crossref: 130] [Cited by in F6Publishing: 131] [Article Influence: 65.0] [Reference Citation Analysis]
38 Torreggiani E, Bononi I, Pietrobon S, Mazzoni E, Guerra G, Feo C, Martini F, Tognon M. Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus. Front Immunol 2021;12:632129. [PMID: 34113338 DOI: 10.3389/fimmu.2021.632129] [Reference Citation Analysis]
39 Lee E, Lee TA, Yoo HJ, Lee S, Park B. CNBP controls tumor cell biology by regulating tumor-promoting gene expression. Mol Carcinog 2019;58:1492-501. [PMID: 31087358 DOI: 10.1002/mc.23030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, Tsoi KKK, Wong MCS, Tse G, Chan MTV, Chan FKL, Ng SC, Wu JCY, Wu WKK, Yu J, Sung JJY, Wong SH. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer. Gastroenterology 2018; 155: 383-390. e8. [PMID: 29729257 DOI: 10.1053/j.gastro.2018.04.028] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 27.7] [Reference Citation Analysis]
41 Garcia-Mazas C, Csaba N, Garcia-Fuentes M. Biomaterials to suppress cancer stem cells and disrupt their tumoral niche. Int J Pharm 2017;523:490-505. [PMID: 27940172 DOI: 10.1016/j.ijpharm.2016.12.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
42 Begka C, Pattaroni C, Mooser C, Nancey S, McCoy KD, Velin D, Maillard MH; Swiss IBD Cohort Study Group. Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer. iScience 2020;23:100891. [PMID: 32114379 DOI: 10.1016/j.isci.2020.100891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Tiwari A, Saraf S, Jain A, Panda PK, Verma A, Jain SK. Basics to advances in nanotherapy of colorectal cancer. Drug Deliv Transl Res 2020;10:319-38. [PMID: 31701486 DOI: 10.1007/s13346-019-00680-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
44 Binder Gallimidi A, Nussbaum G, Hermano E, Weizman B, Meirovitz A, Vlodavsky I, Götte M, Elkin M. Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma. PLoS One 2017;12:e0174343. [PMID: 28350804 DOI: 10.1371/journal.pone.0174343] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
45 Liu L, Gao H, Wen T, Gu T, Zhang S, Yuan Z. Tanshinone IIA attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation. Pharm Biol 2021;59:89-96. [PMID: 33535870 DOI: 10.1080/13880209.2020.1865412] [Reference Citation Analysis]
46 Gelfo V, Romaniello D, Mazzeschi M, Sgarzi M, Grilli G, Morselli A, Manzan B, Rihawi K, Lauriola M. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies. Int J Mol Sci 2020;21:E6009. [PMID: 32825489 DOI: 10.3390/ijms21176009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
47 Li X, Zhang Z, Li L, Gong W, Lazenby AJ, Swanson BJ, Herring LE, Asara JM, Singer JD, Wen H. Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation. J Exp Med 2017;214:1093-109. [PMID: 28280036 DOI: 10.1084/jem.20161105] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
48 Kirshtein A, Akbarinejad S, Hao W, Le T, Su S, Aronow RA, Shahriyari L. Data Driven Mathematical Model of Colon Cancer Progression. J Clin Med 2020;9:E3947. [PMID: 33291412 DOI: 10.3390/jcm9123947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
49 Yan X, Zhao J, Zhang R. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1). Cancer Chemother Pharmacol 2017;80:395-403. [PMID: 28667355 DOI: 10.1007/s00280-017-3365-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
50 Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 2018;18:309-24. [DOI: 10.1038/nri.2017.142] [Cited by in Crossref: 718] [Cited by in F6Publishing: 717] [Article Influence: 239.3] [Reference Citation Analysis]
51 Matos AI, Carreira B, Peres C, Moura LI, Conniot J, Fourniols T, Scomparin A, Martínez-barriocanal Á, Arango D, Conde JP, Préat V, Satchi-fainaro R, Florindo HF. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 2019;307:108-38. [DOI: 10.1016/j.jconrel.2019.06.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
52 Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22:5246. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Vlasova-St Louis I, Bohjanen PR. Post-transcriptional regulation of cytokine and growth factor signaling in cancer. Cytokine Growth Factor Rev 2017;33:83-93. [PMID: 27956133 DOI: 10.1016/j.cytogfr.2016.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
54 Li B, Jiang J, Assaraf YG, Xiao H, Chen Z, Huang C. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification. Drug Resistance Updates 2020;53:100720. [DOI: 10.1016/j.drup.2020.100720] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
55 Campbell H, Fleming N, Roth I, Mehta S, Wiles A, Williams G, Vennin C, Arsic N, Parkin A, Pajic M, Munro F, McNoe L, Black M, McCall J, Slatter TL, Timpson P, Reddel R, Roux P, Print C, Baird MA, Braithwaite AW. ∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling. Nat Commun 2018;9:254. [PMID: 29343721 DOI: 10.1038/s41467-017-02408-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
56 Rao D, Parakrama R, Augustine T, Liu Q, Goel S, Maitra R. Immunotherapeutic advances in gastrointestinal malignancies. NPJ Precis Oncol. 2019;3:4. [PMID: 30729176 DOI: 10.1038/s41698-018-0076-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
57 De Arcangelis A, Hamade H, Alpy F, Normand S, Bruyère E, Lefebvre O, Méchine-Neuville A, Siebert S, Pfister V, Lepage P, Laquerriere P, Dembele D, Delanoye-Crespin A, Rodius S, Robine S, Kedinger M, Van Seuningen I, Simon-Assmann P, Chamaillard M, Labouesse M, Georges-Labouesse E. Hemidesmosome integrity protects the colon against colitis and colorectal cancer. Gut 2017;66:1748-60. [PMID: 27371534 DOI: 10.1136/gutjnl-2015-310847] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
58 Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM. Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci USA. 2016;113:10750-10758. [PMID: 27638202 DOI: 10.1073/pnas.1608077113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
59 Liu Y, Zou L, Wang P, Zhou J, Yuan C, Wang J. Construction of differential expression plasmids of NGF to detect its influence on PC12 cell neuronal differentiation. Exp Ther Med 2021;21:363. [PMID: 33732336 DOI: 10.3892/etm.2021.9794] [Reference Citation Analysis]
60 Gu Y, Wu X, Zhang J, Fang Y, Pan Y, Shu Y, Ma P. The evolving landscape of N6-methyladenosine modification in the tumor microenvironment. Mol Ther 2021;29:1703-15. [PMID: 33839323 DOI: 10.1016/j.ymthe.2021.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lopes-Júnior LC, Olson K, de Omena Bomfim E, Pereira-da-Silva G, Nascimento LC, de Lima RA. Translational research and symptom management in oncology nursing. Br J Nurs 2016;25:S12, S14, S16 passim. [PMID: 27231745 DOI: 10.12968/bjon.2016.25.10.S12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
62 Janssen E, Subtil B, de la Jara Ortiz F, Verheul HMW, Tauriello DVF. Combinatorial Immunotherapies for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1875. [PMID: 32664619 DOI: 10.3390/cancers12071875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
63 Dingle K, Zimek A, Azizieh F, Ansari AR. Establishing a many-cytokine signature via multivariate anomaly detection. Sci Rep 2019;9:9684. [PMID: 31273258 DOI: 10.1038/s41598-019-46097-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Girondel C, Lévesque K, Langlois MJ, Pasquin S, Saba-El-Leil MK, Rivard N, Friesel R, Servant MJ, Gauchat JF, Lesage S, Meloche S. Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis. Oncogene 2021;40:452-64. [PMID: 33177649 DOI: 10.1038/s41388-020-01540-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
65 Tiwari A, Saraf S, Verma A, Panda PK, Jain SK. Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World J Gastroenterol 2018; 24(39): 4428-4435 [PMID: 30357011 DOI: 10.3748/wjg.v24.i39.4428] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
66 Bettini S, Boutet-Robinet E, Cartier C, Coméra C, Gaultier E, Dupuy J, Naud N, Taché S, Grysan P, Reguer S, Thieriet N, Réfrégiers M, Thiaudière D, Cravedi JP, Carrière M, Audinot JN, Pierre FH, Guzylack-Piriou L, Houdeau E. Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep 2017;7:40373. [PMID: 28106049 DOI: 10.1038/srep40373] [Cited by in Crossref: 186] [Cited by in F6Publishing: 154] [Article Influence: 46.5] [Reference Citation Analysis]
67 Gessani S, Belardelli F. Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells. Cancers (Basel) 2019;11:E1491. [PMID: 31623355 DOI: 10.3390/cancers11101491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
68 Watt SK, Hasselbalch HC, Skov V, Kjær L, Thomassen M, Kruse TA, Burton M, Gögenur I. Whole Blood Gene Expression Profiling in patients undergoing colon cancer surgery identifies differential expression of genes involved in immune surveillance, inflammation and carcinogenesis. Surg Oncol 2018;27:208-15. [PMID: 29937173 DOI: 10.1016/j.suronc.2018.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
69 Obraztsov IV, Shirokikh KE, Obraztsova OI, Shapina MV, Wang MH, Khalif IL. Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients. Inflamm Bowel Dis 2019;25:524-31. [PMID: 30544140 DOI: 10.1093/ibd/izy358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
70 Ahuja A, Kim E, Sung GH, Cho JY. STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases. Int J Mol Sci 2020;21:E7675. [PMID: 33081347 DOI: 10.3390/ijms21207675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
71 Geremia A, Arancibia-Cárcamo CV. Innate Lymphoid Cells in Intestinal Inflammation. Front Immunol 2017;8:1296. [PMID: 29081776 DOI: 10.3389/fimmu.2017.01296] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 17.3] [Reference Citation Analysis]
72 Goldman N, Valiuskyte K, Londregan J, Swider A, Somerville J, Riggs JE. Macrophage regulation of B cell proliferation. Cell Immunol 2017;314:54-62. [PMID: 28238361 DOI: 10.1016/j.cellimm.2017.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
73 Yoshikawa T, Wu J, Otsuka M, Kishikawa T, Suzuki N, Takata A, Ohno M, Ishibashi R, Yamagami M, Nakagawa R, Kato N, Miyazawa M, Han J, Koike K. Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis. Gastroenterology 2017;152:631-43. [PMID: 27825961 DOI: 10.1053/j.gastro.2016.10.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
74 Diegeler S, Hellweg CE. Intercellular Communication of Tumor Cells and Immune Cells after Exposure to Different Ionizing Radiation Qualities. Front Immunol 2017;8:664. [PMID: 28638385 DOI: 10.3389/fimmu.2017.00664] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
75 Grazioso TP, Brandt M, Djouder N. Diet, Microbiota, and Colorectal Cancer. iScience 2019;21:168-87. [PMID: 31669832 DOI: 10.1016/j.isci.2019.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
76 Tilg H, Adolph TE, Gerner RR, Moschen AR. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. 2018;33:954-964. [PMID: 29657127 DOI: 10.1016/j.ccell.2018.03.004] [Cited by in Crossref: 235] [Cited by in F6Publishing: 221] [Article Influence: 78.3] [Reference Citation Analysis]
77 Iorio F, Garcia-Alonso L, Brammeld JS, Martincorena I, Wille DR, McDermott U, Saez-Rodriguez J. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich. Sci Rep 2018;8:6713. [PMID: 29713020 DOI: 10.1038/s41598-018-25076-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
78 Xing C, Wang M, Ajibade AA, Tan P, Fu C, Chen L, Zhu M, Hao ZZ, Chu J, Yu X, Yin B, Zhu J, Shen WJ, Duan T, Wang HY, Wang RF. Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host Microbe 2021;29:959-974.e7. [PMID: 33894128 DOI: 10.1016/j.chom.2021.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Ma S, Long T, Huang WJM. Noncoding RNAs in inflammation and colorectal cancer. RNA Biol 2020;17:1628-35. [PMID: 31847691 DOI: 10.1080/15476286.2019.1705610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
80 Jabeen S, Espinoza JA, Torland LA, Zucknick M, Kumar S, Haakensen VD, Lüders T, Engebraaten O, Børresen-Dale AL, Kyte JA, Gromov P, Naume B, Kristensen V, Gromova I, Tekpli X. Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology 2019;8:e1537691. [PMID: 30713794 DOI: 10.1080/2162402X.2018.1537691] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
81 Hwang D, Kim WU. Rheumatoid arthritis: Modelling cytokine signalling networks. Nat Rev Rheumatol 2017;13:5-6. [PMID: 27904145 DOI: 10.1038/nrrheum.2016.194] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
82 Li SQ, Su N, Gong P, Zhang HB, Liu J, Wang D, Sun YP, Zhang Y, Qian F, Zhao B, Yu Y, Ye RD. The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer. Sci Rep 2017;7:5918. [PMID: 28724995 DOI: 10.1038/s41598-017-06368-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
83 Nagasawa M, Spits H, Ros XR. Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. Cold Spring Harb Perspect Biol 2018;10:a030304. [PMID: 29229782 DOI: 10.1101/cshperspect.a030304] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
84 Totaro A, Panciera T, Piccolo S. YAP/TAZ upstream signals and downstream responses. Nat Cell Biol 2018;20:888-99. [PMID: 30050119 DOI: 10.1038/s41556-018-0142-z] [Cited by in Crossref: 291] [Cited by in F6Publishing: 261] [Article Influence: 97.0] [Reference Citation Analysis]
85 de S. L. Oliveira ALC, dos Santos-silva AM, da Silva-júnior AA, Garcia VB, de Araújo AA, de Geus-oei L, Chan AB, Cruz LJ, de Araújo Júnior RF. Cholesterol-functionalized carvedilol-loaded PLGA nanoparticles: anti-inflammatory, antioxidant, and antitumor effects. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-04832-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
86 Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230-240. [PMID: 26882261 DOI: 10.1038/ni.3384] [Cited by in Crossref: 245] [Cited by in F6Publishing: 231] [Article Influence: 49.0] [Reference Citation Analysis]
87 Kwon NS, Kim DS, Yun HY. Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma. Onco Targets Ther 2017;10:2721-8. [PMID: 28579810 DOI: 10.2147/OTT.S138912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
88 Wang J, Zhang C, He W, Gou X. Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma. Front Oncol 2020;10:3. [PMID: 32038982 DOI: 10.3389/fonc.2020.00003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
89 Delgado-Ramirez Y, Colly V, Gonzalez GV, Leon-Cabrera S. Signal transducer and activator of transcription 6 as a target in colon cancer therapy. Oncol Lett 2020;20:455-64. [PMID: 32565970 DOI: 10.3892/ol.2020.11614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Lehmann JS, Zhao A, Sun B, Jiang W, Ji S. Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform. J Vis Exp 2017. [PMID: 29155764 DOI: 10.3791/56440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
91 Hardbower DM, Coburn LA, Asim M, Singh K, Sierra JC, Barry DP, Gobert AP, Piazuelo MB, Washington MK, Wilson KT. EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis. Oncogene 2017;36:3807-19. [PMID: 28263971 DOI: 10.1038/onc.2017.23] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
92 Nishida-Aoki N, Gujral TS. Emerging approaches to study cell-cell interactions in tumor microenvironment. Oncotarget 2019;10:785-97. [PMID: 30774780 DOI: 10.18632/oncotarget.26585] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
93 Iftekhar A, Berger H, Bouznad N, Heuberger J, Boccellato F, Dobrindt U, Hermeking H, Sigal M, Meyer TF. Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells. Nat Commun 2021;12:1003. [PMID: 33579932 DOI: 10.1038/s41467-021-21162-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
94 Janney A, Powrie F, Mann EH. Host–microbiota maladaptation in colorectal cancer. Nature 2020;585:509-17. [DOI: 10.1038/s41586-020-2729-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 34.0] [Reference Citation Analysis]
95 Parakrama R, Fogel E, Chandy C, Augustine T, Coffey M, Tesfa L, Goel S, Maitra R. Immune characterization of metastatic colorectal cancer patients post reovirus administration. BMC Cancer 2020;20:569. [PMID: 32552875 DOI: 10.1186/s12885-020-07038-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
96 Riaz M, Raz Y, van der Slujis B, Dickson G, van Engelen B, Vissing J, Raz V. Cytokine genes as potential biomarkers for muscle weakness in OPMD. Hum Mol Genet 2016;25:4282-7. [PMID: 27506982 DOI: 10.1093/hmg/ddw259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Alzahrani AM, Hanieh H, Ibrahim HM, Mohafez O, Shehata T, Bani Ismail M, Alfwuaires M. Enhancing miR-132 expression by aryl hydrocarbon receptor attenuates tumorigenesis associated with chronic colitis. Int Immunopharmacol 2017;52:342-51. [PMID: 29017096 DOI: 10.1016/j.intimp.2017.09.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
98 Liu C, Liu R, Wang B, Lian J, Yao Y, Sun H, Zhang C, Fang L, Guan X, Shi J, Han S, Zhan F, Luo S, Yao Y, Zheng T, Zhang Y. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. J Immunother Cancer 2021;9:e001895. [PMID: 33462141 DOI: 10.1136/jitc-2020-001895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
99 Jin D, Liu T, Dong W, Zhang Y, Wang S, Xie R, Wang B, Cao H. Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apcmin/+ mice. Oncotarget. 2017;8:97787-97800. [PMID: 29228651 DOI: 10.18632/oncotarget.22081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
100 Yuan Y, Li B, Kuang Y, Ni S, Zhuge A, Yang J, Lv L, Gu S, Yan R, Li Y, Wang K, Yang L, Zhu X, Wu J, Bian X, Li L. The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells. Cancer Cell Int 2020;20:212. [PMID: 32518521 DOI: 10.1186/s12935-020-01305-9] [Reference Citation Analysis]
101 Gao C, Ganesh BP, Shi Z, Shah RR, Fultz R, Major A, Venable S, Lugo M, Hoch K, Chen X, Haag A, Wang TC, Versalovic J. Gut Microbe-Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production. Am J Pathol 2017;187:2323-36. [PMID: 28917668 DOI: 10.1016/j.ajpath.2017.06.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
102 Jiang X, Li Q, Zhang S, Song C, Zheng P. Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer. Onco Targets Ther 2019;12:1059-70. [PMID: 30799935 DOI: 10.2147/OTT.S192290] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
103 Wang A, Ding L, Wu Z, Ding R, Teng XL, Wang F, Hu Z, Chen L, Yu X, Zou Q. ZFP91 is required for the maintenance of regulatory T cell homeostasis and function. J Exp Med 2021;218:e20201217. [PMID: 33355624 DOI: 10.1084/jem.20201217] [Reference Citation Analysis]
104 Zhang Y, Li H, Huang Y, Sun L, Li G. Peptide-induced bio-mineralization as a bio-mimetic means of detecting proteins in a mineralizing bio-context. Nano Res 2016;9:1489-96. [DOI: 10.1007/s12274-016-1045-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
105 Ma X, Lv L, Xing C. Circ_ 0115744 acts as miR-144 sponge to promote and predict the metastasis of colorectal cancer. Aging (Albany NY) 2021;13:5892-905. [PMID: 33591945 DOI: 10.18632/aging.202513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
106 Yang RW, Zeng YY, Wei WT, Cui YM, Sun HY, Cai YL, Nian XX, Hu YT, Quan YP, Jiang SL, Wang M, Zhao YL, Qiu JF, Li MX, Zhang JH, He MR, Liang L, Ding YQ, Liao WT. TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways. J Exp Clin Cancer Res 2016;35:152. [PMID: 27669982 DOI: 10.1186/s13046-016-0426-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
107 Richter KR, Nasr AN, Mexas AM. Cytokine Concentrations Measured by Multiplex Assays in Canine Peripheral Blood Samples. Vet Pathol 2018;55:53-67. [PMID: 28812527 DOI: 10.1177/0300985817725388] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
108 Chen Y, Vandereyken M, Newton IP, Moraga I, Näthke IS, Swamy M. Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22. PLoS Biol 2019;17:e3000540. [PMID: 31770366 DOI: 10.1371/journal.pbio.3000540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Grizzi F, Basso G, Borroni EM, Cavalleri T, Bianchi P, Stifter S, Chiriva-Internati M, Malesci A, Laghi L. Evolving notions on immune response in colorectal cancer and their implications for biomarker development. Inflamm Res. 2018;67:375-389. [PMID: 29322204 DOI: 10.1007/s00011-017-1128-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
110 Rao US, Rao PS. Surface-bound galectin-4 regulates gene transcription and secretion of chemokines in human colorectal cancer cell lines. Tumour Biol 2017;39:1010428317691687. [PMID: 28345468 DOI: 10.1177/1010428317691687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
111 Tawara K, Bolin C, Koncinsky J, Kadaba S, Covert H, Sutherland C, Bond L, Kronz J, Garbow JR, Jorcyk CL. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung. Breast Cancer Res 2018;20:53. [PMID: 29898744 DOI: 10.1186/s13058-018-0971-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
112 Thilakasiri PS, Dmello RS, Nero TL, Parker MW, Ernst M, Chand AL. Repurposing of drugs as STAT3 inhibitors for cancer therapy. Semin Cancer Biol. 2019;. [PMID: 31711994 DOI: 10.1016/j.semcancer.2019.09.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
113 Bess SN, Greening GJ, Muldoon TJ. Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer. Cytokine Growth Factor Rev 2019;49:1-9. [PMID: 31679887 DOI: 10.1016/j.cytogfr.2019.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Çolakoğlu M, Tunçer S, Banerjee S. Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1. Cell Prolif 2018;51:e12472. [PMID: 30062726 DOI: 10.1111/cpr.12472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
115 Paulino DSM, Mendes MCS, Camargo JA, Brambilla SR, Wood Dos Santos T, Ribeiro ML, Carvalheira JBC. Diacerein treatment prevents colitis-associated cancer in mice. World J Clin Oncol 2020; 11(9): 732-746 [PMID: 33033695 DOI: 10.5306/wjco.v11.i9.732] [Reference Citation Analysis]
116 Lin H, Huang H, Yu Y, Chen W, Zhang S, Zhang Y. Nerve growth factor regulates liver cancer cell polarity and motility. Mol Med Rep 2021;23:288. [PMID: 33649819 DOI: 10.3892/mmr.2021.11927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and Colorectal Cancer. Front Oncol. 2018;8:371. [PMID: 30374420 DOI: 10.3389/fonc.2018.00371] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 15.7] [Reference Citation Analysis]
118 Wu B, Tao L, Yang D, Li W, Xu H, He Q. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment. Biomed Res Int 2020;2020:2719739. [PMID: 32908876 DOI: 10.1155/2020/2719739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
119 Vachharajani N, Joeris T, Luu M, Hartmann S, Pautz S, Jenike E, Pantazis G, Prinz I, Hofer MJ, Steinhoff U, Visekruna A. Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7. Oncotarget 2017;8:50447-59. [PMID: 28881574 DOI: 10.18632/oncotarget.14579] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
120 Pujada A, Walter L, Patel A, Bui TA, Zhang Z, Zhang Y, Denning TL, Garg P. Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer. Oncotarget 2017;8:94650-65. [PMID: 29212256 DOI: 10.18632/oncotarget.21841] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
121 Jenkins BJ. Multifaceted Role of IRAK-M in the Promotion of Colon Carcinogenesis via Barrier Dysfunction and STAT3 Oncoprotein Stabilization in Tumors. Cancer Cell 2016;29:615-7. [PMID: 27165738 DOI: 10.1016/j.ccell.2016.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
122 Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, Inflammation and Colorectal Cancer. Cells 2020;9:E618. [PMID: 32143413 DOI: 10.3390/cells9030618] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
123 Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology 2016;5:e1149674. [PMID: 27471617 DOI: 10.1080/2162402X.2016.1149674] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 8.2] [Reference Citation Analysis]
124 García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology 2018;7:e1433982. [PMID: 29872569 DOI: 10.1080/2162402X.2018.1433982] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 8.3] [Reference Citation Analysis]
125 Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, Hu X, Shi T, Tan W, Wang Z. Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3. Eur J Med Chem 2021;211:113027. [PMID: 33248852 DOI: 10.1016/j.ejmech.2020.113027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
126 Zhang J, Shi Z, Xu X, Yu Z, Mi J. The influence of microenvironment on tumor immunotherapy.FEBS J. 2019;286:4160-4175. [PMID: 31365790 DOI: 10.1111/febs.15028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
127 Herrera SC, Bach EA. JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates. Development 2019;146:dev167643. [PMID: 30696713 DOI: 10.1242/dev.167643] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
128 Ismaiel M, Murphy B, Aldhafiri S, Giffney HE, Thornton K, Mukhopadhya A, Keogh CE, Fattah S, Mohan HM, Cummins EP, Murphy EP, Winter DC, Crean D. The NR4A agonist, Cytosporone B, attenuates pro-inflammatory mediators in human colorectal cancer tissue ex vivo. Biochem Biophys Res Commun 2021;554:179-85. [PMID: 33798945 DOI: 10.1016/j.bbrc.2021.03.110] [Reference Citation Analysis]
129 Hata T, Takemasa I, Takahashi H, Haraguchi N, Nishimura J, Hata T, Mizushima T, Doki Y, Mori M. Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer. Br J Cancer. 2017;117:227-232. [PMID: 28632728 DOI: 10.1038/bjc.2017.163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
130 Huang G, Khan I, Li X, Chen L, Leong W, Ho LT, Hsiao WLW. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice. Sci Rep. 2017;7:12552. [PMID: 28970547 DOI: 10.1038/s41598-017-12644-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
131 Kim JH, Shim JW, Eum DY, Kim SD, Choi SH, Yang K, Heo K, Park MT. Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells. Sci Rep 2017;7:2798. [PMID: 28584306 DOI: 10.1038/s41598-017-02935-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
132 Chang YC, Su CY, Chen MH, Chen WS, Chen CL, Hsiao M. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis. Mol Cancer. 2017;16:135. [PMID: 28784136 DOI: 10.1186/s12943-017-0687-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
133 Mao H, Pan F, Wu Z, Wang Z, Zhou Y, Zhang P, Gou M, Dai G. CD19 lo CD27 hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer. DNA and Cell Biology 2017;36:870-7. [DOI: 10.1089/dna.2017.3814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
134 Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, Chen CQ, He YL, Cai SR. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol 2017; 23(34): 6261-6272 [PMID: 28974892 DOI: 10.3748/wjg.v23.i34.6261] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 95] [Article Influence: 24.0] [Reference Citation Analysis]
135 Zhang WH, Wang WQ, Gao HL, Yu XJ, Liu L. The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms. Biochim Biophys Acta Rev Cancer 2019;1872:188311. [PMID: 31442475 DOI: 10.1016/j.bbcan.2019.188311] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
136 Yang Z, Ji G. Fusobacterium nucleatum-positive colorectal cancer. Oncol Lett. 2019;18:975-982. [PMID: 31423156 DOI: 10.3892/ol.2019.10433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
137 Pearce OMT, Delaine-Smith RM, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR, Montfort A, Dowe T, Gribben J, Jones JL, Kocher HM, Serody JS, Vincent BG, Connelly J, Brenton JD, Chelala C, Cutillas PR, Lockley M, Bessant C, Knight MM, Balkwill FR. Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers. Cancer Discov 2018;8:304-19. [PMID: 29196464 DOI: 10.1158/2159-8290.CD-17-0284] [Cited by in Crossref: 133] [Cited by in F6Publishing: 96] [Article Influence: 33.3] [Reference Citation Analysis]
138 Zheng T, Zhang B, Chen C, Ma J, Meng D, Huang J, Hu R, Liu X, Otsu K, Liu AC, Li H, Yin Z, Huang G. Protein kinase p38α signaling in dendritic cells regulates colon inflammation and tumorigenesis. Proc Natl Acad Sci U S A 2018;115:E12313-22. [PMID: 30541887 DOI: 10.1073/pnas.1814705115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
139 Kather JN, Halama N. Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer. Br J Cancer 2019;120:871-82. [PMID: 30936499 DOI: 10.1038/s41416-019-0441-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
140 Lu Y, Li Y, Liu Q, Tian N, Du P, Zhu F, Han Y, Liu X, Liu X, Peng X, Wang X, Wu Y, Tong L, Li Y, Zhu Y, Wu L, Zhang P, Xu Y, Chen H, Li B, Tong X. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment. Gastroenterology 2021;161:575-591.e16. [PMID: 33901495 DOI: 10.1053/j.gastro.2021.04.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
141 Abdalkareem EA, Ong CY, Lim BH, Khoo BY. Neutralizing FGF4 protein in conditioned medium of IL-21-silenced HCT116 cells restores the migratory activity of the colorectal cancer cells. Cytotechnology 2018;70:1363-74. [PMID: 29802489 DOI: 10.1007/s10616-018-0228-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Hlavničková M, Kuchař M, Osička R, Vaňková L, Petroková H, Malý M, Černý J, Arenberger P, Malý P. ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis. Int J Mol Sci 2018;19:E3089. [PMID: 30304852 DOI: 10.3390/ijms19103089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
143 Wu J, Zhao Y, Zhang J, Wu Q, Wang W. Development and validation of an immune-related gene pairs signature in colorectal cancer. Oncoimmunology 2019;8:1596715. [PMID: 31143520 DOI: 10.1080/2162402X.2019.1596715] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 18.5] [Reference Citation Analysis]
144 Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G. Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget. 2016;7:46384-46400. [PMID: 27344176 DOI: 10.18632/oncotarget.10135] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
145 Doulabi H, Rastin M, Shabahangh H, Maddah G, Abdollahi A, Nosratabadi R, Esmaeili SA, Mahmoudi M. Analysis of Th22, Th17 and CD4+cells co-producing IL-17/IL-22 at different stages of human colon cancer. Biomed Pharmacother 2018;103:1101-6. [PMID: 29710675 DOI: 10.1016/j.biopha.2018.04.147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
146 Xue J, Ge X, Zhao W, Xue L, Dai C, Lin F, Peng W. PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling. J Immunol Res 2019;2019:3690561. [PMID: 31781676 DOI: 10.1155/2019/3690561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
147 Rutz S, Eidenschenk C, Kiefer JR, Ouyang W. Post-translational regulation of RORγt—A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases. Cytokine & Growth Factor Reviews 2016;30:1-17. [DOI: 10.1016/j.cytogfr.2016.07.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
148 Li M, Yue GG, Tsui SK, Fung K, Lau CB. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo. Phytomedicine 2018;46:131-41. [DOI: 10.1016/j.phymed.2018.03.065] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
149 Zaharuddin L, Mokhtar NM, Muhammad Nawawi KN, Raja Ali RA. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol. 2019;19:131. [PMID: 31340751 DOI: 10.1186/s12876-019-1047-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
150 Li X, An B, Zhao Q, Qi J, Wang W, Zhang D, Li Z, Qin C. Combined fibrinogen and neutrophil-lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma. Cancer Manag Res 2018;10:6285-94. [PMID: 30568490 DOI: 10.2147/CMAR.S161094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
151 Vecchione R, Quagliariello V, Calabria D, Calcagno V, De Luca E, Iaffaioli RV, Netti PA. Curcumin bioavailability from oil in water nano-emulsions: In vitro and in vivo study on the dimensional, compositional and interactional dependence. J Control Release 2016;233:88-100. [PMID: 27155364 DOI: 10.1016/j.jconrel.2016.05.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
152 Pádua D, Figueira P, Ribeiro I, Almeida R, Mesquita P. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication. Front Cell Dev Biol 2020;8:442. [PMID: 32626705 DOI: 10.3389/fcell.2020.00442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
153 de Vries NL, Swets M, Vahrmeijer AL, Hokland M, Kuppen PJ. The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. Int J Mol Sci 2016;17:E1030. [PMID: 27367680 DOI: 10.3390/ijms17071030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
154 Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol 2021;9:710165. [PMID: 34490259 DOI: 10.3389/fcell.2021.710165] [Reference Citation Analysis]
155 Peh HY, Tan WSD, Chan TK, Pow CW, Foster PS, Wong WSF. Vitamin E isoform γ-tocotrienol protects against emphysema in cigarette smoke-induced COPD. Free Radic Biol Med 2017;110:332-44. [PMID: 28684161 DOI: 10.1016/j.freeradbiomed.2017.06.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
156 Khan AA, Khan Z, Malik A, Kalam MA, Cash P, Ashraf MT, Alshamsan A. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli. Life Sci. 2017;180:60-67. [PMID: 28506682 DOI: 10.1016/j.lfs.2017.05.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
157 Pope JL, Tomkovich S, Yang Y, Jobin C. Microbiota as a mediator of cancer progression and therapy. Transl Res 2017;179:139-54. [PMID: 27554797 DOI: 10.1016/j.trsl.2016.07.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
158 Cho SH, Shim HJ, Park MR, Choi JN, Akanda MR, Hwang JE, Bae WK, Lee KH, Sun EG, Chung IJ. Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling. Cell Death Discov 2021;7:65. [PMID: 33824294 DOI: 10.1038/s41420-021-00447-7] [Reference Citation Analysis]
159 Martin M, Sun M, Motolani A, Lu T. The Pivotal Player: Components of NF-κB Pathway as Promising Biomarkers in Colorectal Cancer. Int J Mol Sci 2021;22:7429. [PMID: 34299049 DOI: 10.3390/ijms22147429] [Reference Citation Analysis]
160 Niclis C, Pou SA, Shivappa N, Hébert JR, Steck SE, Díaz MDP. Proinflammatory Dietary Intake is Associated with Increased Risk of Colorectal Cancer: Results of a Case-Control Study in Argentina Using a Multilevel Modeling Approach. Nutrition and Cancer 2017;70:61-8. [DOI: 10.1080/01635581.2018.1397710] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
161 Rao A, Strauss O, Kokkinou E, Bruchard M, Tripathi KP, Schlums H, Carrasco A, Mazzurana L, Konya V, Villablanca EJ, Björkström NK, Lindforss U, Spits H, Mjösberg J. Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs. Nat Commun 2020;11:2049. [PMID: 32341343 DOI: 10.1038/s41467-020-15695-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
162 Wan M, Ning B, Spiegel S, Lyon CJ, Hu TY. Tumor-derived exosomes (TDEs): How to avoid the sting in the tail. Med Res Rev 2020;40:385-412. [PMID: 31318078 DOI: 10.1002/med.21623] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
163 So SS, Wan ML, El-Nezami H. Probiotics-mediated suppression of cancer. Curr Opin Oncol 2017;29:62-72. [PMID: 27792053 DOI: 10.1097/CCO.0000000000000342] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 9.8] [Reference Citation Analysis]
164 Chen J, Sun W, Zhang H, Ma J, Xu P, Yu Y, Fang H, Zhou L, Lv J, Xie J, Liu Y, Tang K, Huang B. Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β. Cell Mol Immunol 2020;17:1233-44. [PMID: 31649305 DOI: 10.1038/s41423-019-0313-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
165 Herstad KMV, Gunnes G, Rørtveit R, Kolbjørnsen Ø, Tran L, Skancke E. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas. BMC Vet Res 2021;17:119. [PMID: 33712002 DOI: 10.1186/s12917-021-02829-6] [Reference Citation Analysis]
166 MacCarthy-Morrogh L, Martin P. The hallmarks of cancer are also the hallmarks of wound healing. Sci Signal 2020;13:eaay8690. [PMID: 32900881 DOI: 10.1126/scisignal.aay8690] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
167 Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing. Pharmacol Ther 2020;216:107706. [PMID: 33075360 DOI: 10.1016/j.pharmthera.2020.107706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
168 Slowicka K, Petta I, Blancke G, Hoste E, Dumas E, Sze M, Vikkula H, Radaelli E, Haigh JJ, Jonckheere S, Taminau J, Vandamme N, Wullaert A, Tulchinsky E, Nittner D, Van Vlierberghe P, De Hertogh G, Baldin P, Etlioglu E, Wirapati P, Boon L, Lambrecht BN, Callewaert C, Tejpar S, Goossens S, Berx G, Vereecke L, van Loo G. Zeb2 drives invasive and microbiota-dependent colon carcinoma. Nat Cancer 2020;1:620-34. [DOI: 10.1038/s43018-020-0070-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
169 Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 2016;1865:245-54. [PMID: 26980625 DOI: 10.1016/j.bbcan.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
170 Morel PA, Lee REC, Faeder JR. Demystifying the cytokine network: Mathematical models point the way. Cytokine 2017;98:115-23. [PMID: 27919524 DOI: 10.1016/j.cyto.2016.11.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
171 Le T, Aronow RA, Kirshtein A, Shahriyari L. A review of digital cytometry methods: estimating the relative abundance of cell types in a bulk of cells. Brief Bioinform 2021;22:bbaa219. [PMID: 33003193 DOI: 10.1093/bib/bbaa219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
172 Rutz S, Ouyang W. The Itch to degrade ROR-γt. Nat Immunol 2016;17:898-900. [DOI: 10.1038/ni.3516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Thomsen M, Kersten C, Sorbye H, Skovlund E, Glimelius B, Pfeiffer P, Johansen JS, Kure EH, Ikdahl T, Tveit KM, Christoffersen T, Guren TK. Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget 2016;7:75013-22. [PMID: 27738330 DOI: 10.18632/oncotarget.12601] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
174 Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, Wang J, Tang X, Peng Y, Fu X. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018;67:1635-1646. [PMID: 30121899 DOI: 10.1007/s00262-018-2233-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
175 Sun J, Liu X, Gao H, Zhang L, Ji Q, Wang Z, Zhou L, Wang Y, Sui H, Fan Z, Li Q. Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis. Oncotarget 2017;8:11489-506. [PMID: 28009989 DOI: 10.18632/oncotarget.14039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
176 Gunawardene A, Dennett E, Larsen P. Prognostic value of multiple cytokine analysis in colorectal cancer: a systematic review. J Gastrointest Oncol. 2019;10:134-143. [PMID: 30788169 DOI: 10.21037/jgo.2018.07.11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]